BRPI0912615A2 - agonistas de receptor y2 e/ou y4 de longa ação - Google Patents

agonistas de receptor y2 e/ou y4 de longa ação

Info

Publication number
BRPI0912615A2
BRPI0912615A2 BRPI0912615A BRPI0912615A BRPI0912615A2 BR PI0912615 A2 BRPI0912615 A2 BR PI0912615A2 BR PI0912615 A BRPI0912615 A BR PI0912615A BR PI0912615 A BRPI0912615 A BR PI0912615A BR PI0912615 A2 BRPI0912615 A2 BR PI0912615A2
Authority
BR
Brazil
Prior art keywords
acting
long
receptor agonists
agonists
receptor
Prior art date
Application number
BRPI0912615A
Other languages
English (en)
Portuguese (pt)
Inventor
Jacob Kofoed
Jane Spetzler
Rasmus Jorgensen
Sanne Moller Knudsen
Soren Ostergaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BRPI0912615A2 publication Critical patent/BRPI0912615A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0912615A 2008-05-16 2009-05-18 agonistas de receptor y2 e/ou y4 de longa ação BRPI0912615A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08156360 2008-05-16
EP09154461 2009-03-05
PCT/EP2009/055989 WO2009138511A1 (en) 2008-05-16 2009-05-18 Long-acting y2 and/or y4 receptor agonists

Publications (1)

Publication Number Publication Date
BRPI0912615A2 true BRPI0912615A2 (pt) 2016-01-26

Family

ID=40934036

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912615A BRPI0912615A2 (pt) 2008-05-16 2009-05-18 agonistas de receptor y2 e/ou y4 de longa ação

Country Status (12)

Country Link
US (1) US20110275559A1 (enExample)
EP (1) EP2279204A1 (enExample)
JP (1) JP2011520847A (enExample)
KR (1) KR20110017874A (enExample)
CN (1) CN102027007A (enExample)
AU (1) AU2009248041B2 (enExample)
BR (1) BRPI0912615A2 (enExample)
CA (1) CA2723855A1 (enExample)
IL (1) IL208836A0 (enExample)
MX (1) MX2010011845A (enExample)
RU (1) RU2504550C2 (enExample)
WO (1) WO2009138511A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5767582B2 (ja) 2009-07-02 2015-08-19 武田薬品工業株式会社 ペプチド及びその用途
WO2011033068A1 (en) * 2009-09-18 2011-03-24 Novo Nordisk A/S Long-acting y2 receptor agonists
JP2013510829A (ja) * 2009-11-13 2013-03-28 ノヴォ ノルディスク アー／エス 長時間作用型ｙ２受容体アゴニスト
GB201001333D0 (en) * 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
US8927687B2 (en) 2010-07-09 2015-01-06 Amylin Pharmaceuticals, Llc Microcrystalline Y receptor agonists
WO2012080471A1 (en) 2010-12-16 2012-06-21 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
MY171146A (en) 2012-03-22 2019-09-27 Novo Nordisk As Compositions of glp-1 peptides and preparation thereof
PT2991671T (pt) 2013-05-02 2018-11-05 Novo Nordisk As Dosagem oral de compostos de glp-1
EP2842965A1 (en) 2013-09-03 2015-03-04 Gubra ApS Neuromedin U analogs comprising serum albumin binding amino acid residue
KR20160075819A (ko) 2013-11-15 2016-06-29 노보 노르디스크 에이/에스 선택적 pyy 화합물 및 그것의 사용
HRP20191036T1 (hr) * 2013-11-15 2019-09-06 Novo Nordisk A/S Selektivni spojevi pyy i njihova upotreba
WO2015073878A1 (en) * 2013-11-15 2015-05-21 Ur Diet, Llc Real-time satiety biofeedback
WO2015071356A1 (en) 2013-11-15 2015-05-21 Novo Nordisk A/S Hpyy(1 -36) having a beta-homoarginine substitution at position 35
KR102393642B1 (ko) 2014-01-17 2022-05-03 리플리겐 코포레이션 크로마토그래피 컬럼 살균
US20240100450A9 (en) * 2014-01-17 2024-03-28 Repligen Corporation Sterilizing chromatography columns
US10533039B2 (en) * 2014-05-21 2020-01-14 President And Fellows Of Harvard College Ras inhibitory peptides and uses thereof
EP3307768B1 (en) * 2015-06-12 2025-01-29 Novo Nordisk A/S Selective pyy compounds and uses thereof
MA53076B1 (fr) 2018-02-02 2023-11-30 Novo Nordisk As Compositions solides comportant un agoniste glp-1, du sel d'acide n-(8-(2-hydroxybenzoyl)amino)caprylate et un lubrifiant
TWI749381B (zh) * 2018-11-01 2021-12-11 美商美國禮來大藥廠 蛋白質酪胺酸-酪胺酸類似物及其使用方法
GB201908426D0 (en) * 2019-06-12 2019-07-24 Imp College Innovations Ltd Appetite suppressing compounds
IL297368A (en) * 2020-04-17 2022-12-01 I2O Therapeutics Inc Long-acting peptide tyrosine kinase (pyy) analogs and methods of use
CA3215858A1 (en) 2021-04-27 2022-11-03 Zhenhuan ZHENG Combination of bitter receptor agonist and gut-signaling compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2275207C2 (ru) * 2000-12-14 2006-04-27 Амилин Фармасьютикалз, Инк. Способ снижения доступности питательного вещества, способ подавления аппетита
EP2932981B1 (en) * 2003-09-19 2021-06-16 Novo Nordisk A/S Albumin-binding derivatives of GLP-1
WO2005077094A2 (en) * 2004-02-11 2005-08-25 Amylin Pharmaceuticals, Inc. Pancreatic polypeptide family motifs and polypeptides comprising the same
CA2560174A1 (en) * 2004-03-17 2005-09-29 7Tm Pharma A/S Y4 selective receptor agonists for therapeutic interventions
BRPI0512988A (pt) * 2004-07-08 2008-04-22 Novo Nordisk As método para aumentar a meia-vida plasmática de uma molécula, composto, uso do mesmo, e, composição farmacêutica
KR20080031414A (ko) * 2005-07-18 2008-04-08 노보 노르디스크 에이/에스 비만치료에 사용하기 위한 신규 펩티드

Also Published As

Publication number Publication date
AU2009248041B2 (en) 2013-10-03
IL208836A0 (en) 2011-01-31
RU2504550C2 (ru) 2014-01-20
CN102027007A (zh) 2011-04-20
US20110275559A1 (en) 2011-11-10
WO2009138511A1 (en) 2009-11-19
CA2723855A1 (en) 2009-11-19
JP2011520847A (ja) 2011-07-21
MX2010011845A (es) 2010-11-22
EP2279204A1 (en) 2011-02-02
AU2009248041A1 (en) 2009-11-19
RU2010149474A (ru) 2012-06-27
KR20110017874A (ko) 2011-02-22

Similar Documents

Publication Publication Date Title
BRPI0912615A2 (pt) agonistas de receptor y2 e/ou y4 de longa ação
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
BRPI0922483A2 (pt) agonista de receptor gpr120 e usos dos mesmos
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
PL3722310T3 (pl) Stabilne i rozpuszczalne przeciwciała hamujące vegf
BRPI0911242A2 (pt) conjunto de articulação e/ou mancal
BRPI0921822A2 (pt) composição compreendendo polímero e enzima
DK2313111T3 (da) Toll-lignende receptoragonistformuleringer og anvendelse deraf
BRPI0912046A2 (pt) composições de hibridização e métodos
BRPI0910925A2 (pt) conjuntos de transferência de líquido e métodos relacionados
BRPI0913024A2 (pt) lista de mensagens e painel de leitura de mensagens sincronizados centrados na conversação
ATE476966T1 (de) Feste dispersion mit schwer wasserlöslichem wirkstoff
BRPI0809978A2 (pt) Dispositivos e métodos de dispensação de gotículas
BRPI0807473A2 (pt) Recipiente, javre e conjunto de recipiente e javre
BRPI0811450A2 (pt) Montagens de dobradiça e de vaso sanitário.
BRPI0807911A2 (pt) Agonistas de alfa2c adrenorreceptor
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BRPI0911618A2 (pt) antagonistas da via hedgehog de ftalazina dissubstituída.
EP2284538A4 (en) Biosensor
BRPI0921230A2 (pt) agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo.
BRPI0909322A2 (pt) Método e aparelho de gerenciamento de lista
EP2388085A4 (en) AGITATION DEVICE, FUSION APPARATUS, AND FUSION METHOD
EP2280284A4 (en) Biosensor
BRPI0914098A2 (pt) biosensor
BRPI0911337A2 (pt) rolamento de deslizamento

Legal Events

Date Code Title Description
B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO, SOLICITADA ATRAVES DA PETICAO ELETRONICA WBRJ NO 860140167707 DE 03/10/2014.

B10H Cessation: republication